vs
Acadia Healthcare Company, Inc.（ACHC）与安朗杰（ALLE）财务数据对比。点击上方公司名可切换其他公司
安朗杰的季度营收约是Acadia Healthcare Company, Inc.的1.2倍（$1.0B vs $829.0M），安朗杰净利率更高（13.4% vs 0.5%，领先12.8%），安朗杰同比增速更快（9.7% vs 7.5%），过去两年安朗杰的营收复合增速更高（3.5% vs 2.0%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
安朗杰是全球知名的安防产品及解决方案供应商，面向全球生产销售机械与电子类安防产品，包括闭门器、出入口控制设备、锁具、电子门禁系统、考勤与人员效能管理系统、门体系统及相关配件，服务商业、公共机构、住宅等多领域终端用户
ACHC vs ALLE — 直观对比
营收规模更大
ALLE
是对方的1.2倍
$829.0M
营收增速更快
ALLE
高出2.2%
7.5%
净利率更高
ALLE
高出12.8%
0.5%
两年增速更快
ALLE
近两年复合增速
2.0%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $829.0M | $1.0B |
| 净利润 | $4.5M | $138.1M |
| 毛利率 | — | 44.0% |
| 营业利润率 | — | 18.9% |
| 净利率 | 0.5% | 13.4% |
| 营收同比 | 7.5% | 9.7% |
| 净利润同比 | -50.8% | -6.8% |
| 每股收益（稀释后） | $0.05 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCALLE
| Q1 26 | $829.0M | $1.0B | ||
| Q4 25 | $821.5M | $1.0B | ||
| Q3 25 | $851.6M | $1.1B | ||
| Q2 25 | $869.2M | $1.0B | ||
| Q1 25 | $770.5M | $941.9M | ||
| Q4 24 | $774.2M | $945.6M | ||
| Q3 24 | $815.6M | $967.1M | ||
| Q2 24 | $796.0M | $965.6M |
净利润ACHCALLE
| Q1 26 | $4.5M | $138.1M | ||
| Q4 25 | $-1.2B | $147.5M | ||
| Q3 25 | $36.2M | $188.4M | ||
| Q2 25 | $30.1M | $159.7M | ||
| Q1 25 | $8.4M | $148.2M | ||
| Q4 24 | $32.6M | $144.1M | ||
| Q3 24 | $68.1M | $174.2M | ||
| Q2 24 | $78.5M | $155.4M |
毛利率ACHCALLE
| Q1 26 | — | 44.0% | ||
| Q4 25 | — | 44.5% | ||
| Q3 25 | — | 45.8% | ||
| Q2 25 | — | 45.6% | ||
| Q1 25 | — | 44.9% | ||
| Q4 24 | — | 44.1% | ||
| Q3 24 | — | 44.7% | ||
| Q2 24 | — | 44.4% |
营业利润率ACHCALLE
| Q1 26 | — | 18.9% | ||
| Q4 25 | -142.4% | 20.3% | ||
| Q3 25 | 4.7% | 21.8% | ||
| Q2 25 | 5.8% | 21.5% | ||
| Q1 25 | 1.7% | 20.9% | ||
| Q4 24 | 4.9% | 19.5% | ||
| Q3 24 | 12.1% | 22.2% | ||
| Q2 24 | 13.4% | 21.6% |
净利率ACHCALLE
| Q1 26 | 0.5% | 13.4% | ||
| Q4 25 | -143.3% | 14.3% | ||
| Q3 25 | 4.3% | 17.6% | ||
| Q2 25 | 3.5% | 15.6% | ||
| Q1 25 | 1.1% | 15.7% | ||
| Q4 24 | 4.2% | 15.2% | ||
| Q3 24 | 8.4% | 18.0% | ||
| Q2 24 | 9.9% | 16.1% |
每股收益（稀释后）ACHCALLE
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $1.70 | ||
| Q3 25 | $0.40 | $2.18 | ||
| Q2 25 | $0.33 | $1.85 | ||
| Q1 25 | $0.09 | $1.71 | ||
| Q4 24 | $0.36 | $1.65 | ||
| Q3 24 | $0.74 | $1.99 | ||
| Q2 24 | $0.85 | $1.77 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $158.5M | $308.9M |
| 总债务越低越好 | $2.5B | $2.0B |
| 股东权益账面价值 | $2.0B | $2.1B |
| 总资产 | $5.5B | $5.3B |
| 负债/权益比越低杠杆越低 | 1.29× | 0.97× |
8季度趋势，按日历期对齐
现金及短期投资ACHCALLE
| Q1 26 | $158.5M | $308.9M | ||
| Q4 25 | $133.2M | $356.2M | ||
| Q3 25 | $118.7M | $302.7M | ||
| Q2 25 | $131.4M | $656.8M | ||
| Q1 25 | $91.2M | $494.5M | ||
| Q4 24 | $76.3M | $503.8M | ||
| Q3 24 | $82.1M | $878.9M | ||
| Q2 24 | $77.2M | $747.5M |
总债务ACHCALLE
| Q1 26 | $2.5B | $2.0B | ||
| Q4 25 | $2.5B | $2.0B | ||
| Q3 25 | $2.3B | $2.1B | ||
| Q2 25 | $2.3B | $2.1B | ||
| Q1 25 | $2.2B | $2.0B | ||
| Q4 24 | $2.0B | $2.0B | ||
| Q3 24 | $1.9B | $2.4B | ||
| Q2 24 | $1.8B | $2.4B |
股东权益ACHCALLE
| Q1 26 | $2.0B | $2.1B | ||
| Q4 25 | $1.9B | $2.1B | ||
| Q3 25 | $3.1B | $1.9B | ||
| Q2 25 | $3.1B | $1.8B | ||
| Q1 25 | $3.0B | $1.6B | ||
| Q4 24 | $3.1B | $1.5B | ||
| Q3 24 | $3.0B | $1.6B | ||
| Q2 24 | $3.0B | $1.4B |
总资产ACHCALLE
| Q1 26 | $5.5B | $5.3B | ||
| Q4 25 | $5.5B | $5.2B | ||
| Q3 25 | $6.4B | $5.2B | ||
| Q2 25 | $6.3B | $4.9B | ||
| Q1 25 | $6.1B | $4.6B | ||
| Q4 24 | $6.0B | $4.5B | ||
| Q3 24 | $5.9B | $5.0B | ||
| Q2 24 | $5.7B | $4.8B |
负债/权益比ACHCALLE
| Q1 26 | 1.29× | 0.97× | ||
| Q4 25 | 1.28× | 0.96× | ||
| Q3 25 | 0.74× | 1.07× | ||
| Q2 25 | 0.74× | 1.16× | ||
| Q1 25 | 0.72× | 1.24× | ||
| Q4 24 | 0.64× | 1.33× | ||
| Q3 24 | 0.62× | 1.53× | ||
| Q2 24 | 0.62× | 1.69× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.5M | $101.3M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 2.0% |
| 现金转化率经营现金流/净利润 | 13.78× | 0.73× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACHCALLE
| Q1 26 | $61.5M | $101.3M | ||
| Q4 25 | $-86.3M | $240.1M | ||
| Q3 25 | $73.2M | $229.5M | ||
| Q2 25 | $133.5M | $209.7M | ||
| Q1 25 | $11.5M | $104.5M | ||
| Q4 24 | $116.7M | $219.0M | ||
| Q3 24 | $163.1M | $231.9M | ||
| Q2 24 | $171.1M | $173.0M |
自由现金流ACHCALLE
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $200.5M | ||
| Q3 25 | $-63.0M | $209.8M | ||
| Q2 25 | $-34.2M | $192.0M | ||
| Q1 25 | $-163.2M | $83.4M | ||
| Q4 24 | $-86.8M | $194.9M | ||
| Q3 24 | $-27.1M | $212.0M | ||
| Q2 24 | $16.9M | $152.1M |
自由现金流率ACHCALLE
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 19.4% | ||
| Q3 25 | -7.4% | 19.6% | ||
| Q2 25 | -3.9% | 18.8% | ||
| Q1 25 | -21.2% | 8.9% | ||
| Q4 24 | -11.2% | 20.6% | ||
| Q3 24 | -3.3% | 21.9% | ||
| Q2 24 | 2.1% | 15.8% |
资本支出强度ACHCALLE
| Q1 26 | — | 2.0% | ||
| Q4 25 | 11.3% | 3.8% | ||
| Q3 25 | 16.0% | 1.8% | ||
| Q2 25 | 19.3% | 1.7% | ||
| Q1 25 | 22.7% | 2.2% | ||
| Q4 24 | 26.3% | 2.5% | ||
| Q3 24 | 23.3% | 2.1% | ||
| Q2 24 | 19.4% | 2.2% |
现金转化率ACHCALLE
| Q1 26 | 13.78× | 0.73× | ||
| Q4 25 | — | 1.63× | ||
| Q3 25 | 2.02× | 1.22× | ||
| Q2 25 | 4.43× | 1.31× | ||
| Q1 25 | 1.37× | 0.71× | ||
| Q4 24 | 3.58× | 1.52× | ||
| Q3 24 | 2.39× | 1.33× | ||
| Q2 24 | 2.18× | 1.11× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
ALLE
| Allegion Americas | $809.9M | 78% |
| Allegion International | $223.7M | 22% |
